The Patent Finder

GP Pharm, S.A.

Also on record
Records under this name other than patents GP Pharm, S.A. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 6 of 6 · Back to GP Pharm, S.A.

PatentTitleStatus Expires Confidence
US 8,993,521Oral Pharmaceutical Composition of Desmopressin
Formerly held
In force
 · High confidence
In forceHigh confidence
US 9,789,064Method for delivering a peptide to a subject at a modulated rate via microcapsules of lactic-co-glycolic copolymer containing said peptide
Term ended
Term ended Dec 15, 2020 · From the USPTO record
Term endedTerm ended Dec 15, 2020From the USPTO record
US 6,521,599Stable pharmaceutical formulation for intravenous or intramuscular administration of active peptide compounds
Lapsed on the fee record
Ended Feb 18, 2015 · From the USPTO record
Lapsed on the fee recordEnded Feb 18, 2015From the USPTO record
US 7,153,490Liposomes encapsulating anticancer drugs and use thereof in the treatment of malignant tumors
Lapsed on the fee record
Ended Dec 26, 2014 · From the USPTO record
Lapsed on the fee recordEnded Dec 26, 2014From the USPTO record
US 5,605,703Liposomes encapsulating doxorubicin
Term ended
Term ended no later than Feb 25, 2017 · Low confidence
Term endedTerm ended no later than Feb 25, 2017Low confidence
US 5,736,161Pharmaceutical preparation for improving the bioavailability of drugs which are difficult to absorb and a procedure for obtaining it
Term ended
Term ended no later than Apr 7, 2018 · Low confidence
Term endedTerm ended no later than Apr 7, 2018Low confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited